Genitourinary pathogens and preterm birth

Current Opinion in Infectious Diseases

Volumn 26, Issue 3, 2013, Pages 219-230

  Cunnington, Marianne ^a   Kortsalioudaki, Christini ^b   Heath, Paul ^b  

^a Novartis Vaccines and Diagnostics   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

genitourinary infection; preterm birth; screening

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE;

ASYMPTOMATIC BACTERIURIA; BACTERIAL COLONIZATION; BACTERIURIA; CANDIDA; CASE CONTROL STUDY; CHLAMYDIA; CHORIOAMNIONITIS; COHORT ANALYSIS; DISEASE ASSOCIATION; GONORRHEA; HUMAN; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING; STREPTOCOCCUS AGALACTIAE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URINARY TRACT INFECTION; VAGINITIS;

BACTERIURIA; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84876871522     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328360dc31     Document Type: Review

References (78)

1. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012; 379:2162-2172.
2. Liu L, Johnson HL, Cousens S, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since. Lancet 2012; 379:2151-2161.
3. Lawn JE, Kerber K, Enweronu-Laryea C, et al. 3.6 million neonatal deaths: what is progressing and what is not? Semin Perinatol 2010; 34:371- 386.
4. Lockwood CJ, Kuczynski E. Markers of risk for preterm delivery. J Perinat Med 1999; 27:5-20.
5. Watts DH, Krohn MA, Hillier SL, et al. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992; 79:351-357.
6. Russell P. Inflammatory lesions of the human placenta. I. Clinical significance of acute chorioamnionitis. Am J Diagn Gynecol Obstet 1979; 1:127-137.
7. Romero R, Sirtori M, Oyarzun E, et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161:817- 824.
8. McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170:1048- 1059.
9. Lockwood CJ. Predicting premature delivery: no easy task. N Engl J Med 2002; 346:282-284.
10. Hillier SL, Krohn MA, Kiviat NB, et al. Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol 1991; 165 (4 Pt 1):955-961.
11. Keelan JA, Blumenstein M, Helliwell RJ, et al. Cytokines, prostaglandins and parturition: a review. Placenta 2003; 24 (Suppl A):S33-S46.
12. Challis JR, Lye SJ, Gibb W, et al. Understanding preterm labor. Ann N Y Acad Sci 2001; 943:225-234.
13. Cotch MF, Pastorek JG 2, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24:353-360.
14. Stringer E, Read JS, Hoffman I, et al. Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birth. S Afr Med J 2010; 100:58-64.
15. Hitti J, Nugent R, Boutain D, et al. Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol 2007; 21:330-337.
16. French JI, McGregor JA, Parker R. Readily treatable reproductive tract infections and preterm birth among black women. Am J Obstet Gynecol 2006; 194:1717-1726.
17. Mann JR, McDermott S, Zhou L, et al. Treatment of trichomoniasis in pregnancy and preterm birth: an observational study. J Womens Health 2009; 18:493-497.
18. Mann JR, McDermott S, Gill T. Sexually transmitted infection is associated with increased risk of preterm birth in South Carolina women insured by Medicaid. J Matern Fetal Neonatal Med 2010; 23:563-568.
19. Johnson HL, Ghanem KG, Zenilman JM, et al. Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics. Sex Trans Dis 2011; 38:167- 171.
20. Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. Br Med J 2004; 329:371.
21. Roberts CL, Rickard K, Kotsiou G, et al. Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Pregnancy Childbirth 2011; 11:18.
22. Kiss H, Petricevic L, Martina S, et al. Reducing the rate of preterm birth through a simple antenatal screen-and-treat programme: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 2010; 153:38-42.
23. Andrews WW, Klebanoff MA, Thom EA, et al. Midpregnancy genitourinary tract infection with Chlamydia trachomatis: association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis. Am J Obstet Gynecol 2006; 194:493-500.
24. Rastogi S, Das B, Salhan S, et al. Effect of treatment for Chlamydia trachomatis during pregnancy. Int J Gynaecol Obstet 2003; 80:129-137.
25. Rours GI, Duijts L, Moll HA, et al. Chlamydia trachomatis infection during pregnancy associated with preterm delivery: a population-based prospective cohort study. Eur J Epidemiol 2011; 26:493-502.
26. Blas MM, Canchihuaman FA, Alva IEHSE. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Trans Infect 2007; 83:314-318.
27. Chow JM, Kang MS, Samuel MC, et al. Assessment of the association of Chlamydia trachomatis infection and adverse perinatal outcomes with the use of population-based Chlamydia case report registries and birth records. Public Health Reports 2009; 124 (S2):24-30.
28. Silveira MF, Ghanem KG, Erbelding EJ, et al. Chlamydia trachomatis infection during pregnancy and the risk of preterm birth: a case-control study. Int J STD AIDS 2009; 20:465-469.
29. Carey JC, Klebanoff MA. Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol 2005; 192:1341- 1346.
30. Bastek JA, Sammel MD, Srinivas SK, et al. Is routine infectious and toxicologic screening in preterm labor effective in predicting preterm birth? Am J Obstet Gynecol 2008; 198:e38-e42.
31. Gojnic M, Pervulov M, Boskovic V, et al. Bacterial infections: the cause of preterm delivery. Clin Exp Obstet Gynecol 2005; 32:35-36.
32. Lumbiganon P, Villar J, Laopaiboon M, et al. One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. Obstet Gynecol 2009; 113 (2 Pt1):339-345.
33. Sheiner E, Mazor-Drey E, Levy A. Asymptomatic bacteriuria during pregnancy. J Matern Fetal Neonatal Med 2009; 22:423-427.
34. Marahatta R, Acharya Dhungel B, Pradhan P, et al. Asymptomatic bacteriurea among pregnant women visiting Nepal Medical College Teaching Hospital, Kathmandu, Nepal. Nepal Med Coll J 2011; 13:107-110.
35. Ullah MA, Barman A, Siddique MA, et al. Prevalence of asymptomatic bacteriuria and its consequences in pregnancy in a rural community of Bangladesh. Bangladesh Med Res Counc Bull 2007; 33:60-64.
36. Gulmezoglu AM, Azhar AM. Interventions for trichomoniasis in pregnancy. Cochrane Database Syst Rev 2011; 5:CD000220.
37. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345:487-493.
38. Sangkomkamhang US, Lumbiganon P, Prasertcharoensook W, Laopaiboon M. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery (Review). Cochrane Database Syst Rev 2008; 2:CD006178.
39. Klein LL, Gibbs RS. Infection and preterm birth. Obstet Gynecol Clin North Am 2005; 32:397-410.
40. Committee on Practice Bulletins-Obstetrics. The American College of Obstetrics and Gynecologists. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol 2012; 120:964-973.
41. Royal College of Obstetricians and Gynaecologists. Infection and pregnancy: study group statement. 2013. Available from: http://www.rcog.org.uk/ womens-health/clinical-guidance/infection-and-pregnancy-study-group-state ment.
42. National Institute for Clinical Excellence. Antenatal care. 2010. Report No.: NICE clinical guideline 62.
43. Workowski KA, Berman S, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1-109.
44. Cotch MF, Hillier SL, Gibbs RS, et al. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1998; 178:374-380.
45. Mardh PA. Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring. Best Pract Res Clin Obstet Gynaecol 2002; 16:847-864.
46. Edwards MS, Nizet V, Baker CJ. Group B streptococcal infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, editors. Infectious diseases of the fetus and newborn infant, 6th ed. Philadelphia: Elsevier Saunders; pp. 403-464.
47. Hecht JL, Onderdonk A, Delaney M, et al. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol 2008; 11:15-22.
48. Valkenburg-van den Berg AW, Sprij AJ, Dekker FW, et al. Association between colonization with Group B Streptococcus and preterm delivery: a systematic review. Acta Obstet Gynecol Scand 2009; 88:958-967.
49. Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J 2011; 30:759-763.
50. Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59:1-36.
51. Ba'nhidy F, Acs N, Puhó EH, et al. Pregnancy complications and birth outcomes of pregnant women with urinary tract infections and related drug treatments. Scand J Infect Dis 2007; 39:390-397.
52. Mazor-Dray E, Levy A, Schlaeffer F, et al. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med 2009; 22:124-128.
53. Freak-Poli R, Chan A, Tucker G, et al. Previous abortion and risk of preterm birth: a population study. J Matern Fetal Neonatal Med 2009; 22:1-7.
54. Chen YK, Chen SF, Li HC, et al. No increased risk of adverse pregnancy outcomes in women with urinary tract infections: a nationwide populationbased study. Acta Obstet Gynecol Scand 2010; 89:882-889.
55. Morken NH, Gunnes N, Magnus P, et al. Risk of spontaneous preterm delivery in a low-risk population: the impact of maternal febrile episodes, urinary tract infection, pneumonia and ear-nose-throat infections. Eur J Obstet Gynecol Reprod Biol 2011; 159:310-314.
56. U.S. Preventive Services Task Force. Screening for asymptomatic bacteriuria in adults. 2008. http://www.uspreventiveservicestaskforce.org/ uspstf/uspsbact. htm.
57. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2007; 2:CD000490.
58. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003; 189:139-147.
59. Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000; 342:534-540.
60. McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy (Review). Cochrane Database Syst Rev 2007; 1:CD000262.
61. Sungkar A, Purwosunu Y, Aziz MF, et al. Influence of early self-diagnosis and treatment of bacterial vaginosis on preterm birth rate. Int J Gynaecol Obstet 2012; 117:264-267.
62. Krauss-Silva L, Moreira ME, Alves MB, et al. A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials 2011; 12:239.
63. Hendler I, Andrews WW, Carey CJ, et al. The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women. Am J Obstet Gynecol 2007; 197:488e1- 488e5.
64. Ugwumadu A, Manyonda I, Reid F, et al. Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomised controlled trial. Lancet 2003; 361:983-988.
65. Camargo RP, Simoes JA, Cecatti JG, et al. Impact of treatment for bacterial vaginosis on prematurity among Brazilian pregnant women: a retrospective cohort study. Sao Paulo Med J 2005; 123:108-112.
66. Oakeshott P, Kerry S, Hay S, et al. Bacterial vaginosis and preterm birth: a prospective community-based cohort study. Br J Gen Prac 2004; 54:119- 122.
67. Donders GG, Van Calsteren K, Bellen G, et al. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. Br J Obstet Gynaecol 2009; 116:1315- 1324.
68. Klebanoff MA, Hillier SL, Nugent RP, et al. Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol 2005; 192:470-477.
69. De Seta F, Sartore A, Piccoli M, et al. Bacterial vaginosis and preterm delivery: an open question. J Reprod Med 2005; 50:313-318.
70. Svare JA, Schmidt H, Hansen BB, et al. Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. Br J Obstet Gynaecol 2006; 113:1419-1425.
71. Daskalakis G, Papapanagiotou A, Mesogitis S, et al. Bacterial vaginosis and group B streptococcal colonization and preterm delivery in a low-risk population. Fetal Diagn Ther 2006; 21:172-176.
72. Thorsen P, Vogel I, Olsen J, et al. Risk factors for bacterial vaginosis in pregnancy: a population-based study on Danish women. J Matern Fetal Neonatal Med 2006; 19:1-7.
73. Laxmi U, Agrawal S, Raghunandan C, et al. Association of bacterial vaginosis with adverse fetomaternal outcome in women with spontaneous preterm labor: a prospective cohort study. JMatern Fetal Neonatal Med 2012; 25:64- 67.
74. Azargoon A, Darvishzadeh S. Association of bacterial vaginosis, Trichomonas vaginalis, and vaginal acidity with outcome of pregnancy. Arch Iran Med 2006; 9:213-217.
75. Mascagni JR, Miller LH. A descriptive correlational study of bacterial vaginosis in pregnancy and its association with preterm birth: implications for advanced practice nurses. J Am Acad Nurse Pract 2004; 16:555-560.
76. Goffinet F, Maillard F, Mihoubi N, et al. Bacterial vaginosis: prevalence and predictive value for premature delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol 2003; 108:146-151.
77. Stevens AO, Chauhan SP, Magann EF, et al. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor. Am J Obstet Gynecol 2004; 190:1582-1587.
78. Das TR, Jahan S, Begum SR, et al. Association between bacterial vaginosis and preterm delivery. Mymensingh Med J 2011; 20:115-120.